Fortress Biotech 10K 2018 Annual report | FBIO Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: AACR, abdominoplasty, acid, advent, affinity, ahead, aimed, Aldeanueva, Alexion, Almirall, amenable, andin, anin, Ankara, antibacterial, antibiotic, antifungal, antimicrobial, antitumor, appellate, area, arose, ASH, athlete, auditor, barrier, BBA, Bipartisan, bladder, blast, blastic, blood, bothin, boy, BPDCN, breast, broadening, bubble, burden, burning, Cantor, capsule, carcinoma, cardiac, catastrophic, catecholamine, certified, CFO, cheaper, chemotherapy, chronic, Cipla, classic, CML, CNS, cohort, colon, colorectal, combinatorial, contemplated, contended, context, ConVax, correlation, cosmeceutical, Covenant, CRACC, dataset, deficiency, dendritic, density, destruction, diagnosed, dictated, die, dissolve, distinct, divestiture, Doryx, DOSPA, drafting, dressing, Dysferlinopathy, dysplasia, earliest, earner, EBMT, Echocardiography, elotuzumab, Empliciti, endometrial, endpoint, entrepreneurial, European, Exelderm, Exelderm®in, expedient, exploring, Farmaceutyczne, FASBissued, Fast, faster, fitting, Fitzgerald, fluid, follicular, foot, foregone, foremost, fungal, furlough, furniture, Gao, gave, GBM, glioma, GLS, glutamic, glycoprotein, graft, great, grown, Guangping, guaranty, hairy, hearing, heterodimeric, HHS, hinder, Hodgkin, host, HTHC, humoral, hydrocortisone, IASLC, imaging, immunodeficiency, immunogenic, immunogenicity, impending, inauguration, incentivize, incurrence, indemnitor, inflammatory, inJCI, inMolecular, Insight, insoluble, interdependent, InvaGen, itch, itching, jock, Jose, journalBiology, Jude, judge, jurisdiction, Kahlon, kappa, kinase, KSet, Ladenburg, lambda, landscape, leadership, lentiviral, lethal, lieu, LifeSci, lifted, longitudinal, Luzu, lymphoblastic, lymphoma, lymphoplasmacytic, machinery, Madison, malignancy, malignant, mantle, marking, Mayne, meant, median, mediate, metastasized, minocycline, mixed, MM, Modernization, morbidity, movement, mutated, myocardial, Naftin, Nanodysferlin, nanomolar, Nationwide, natriuretic, neoplasm, NHC, NHL, niche, Noble, Nonemployee, nurse, older, opposed, Ortho, OTC, outdated, overexpressed, payor, peptide, persistence, phosphoprotein, physician, placebo, placenta, plasmacytoid, platform, Polpharma, poor, proliferation, prophylactic, pruritic, radiolabeled, ran, recipient, recoup, recouping, redirect, redundant, Reed, Ref, refinance, refinancing, refine, relieve, renal, resection, resistance, resistant, ringworm, rituximab, robustin, ROU, Sebela, sector, setback, SEYSARA, shear, shedding, shipping, shut, shutdown, Simplification, softgel, soluble, solution, Song, SPMA, sponsorship, spread, SRA, St, stable, stomach, subunit, superseded, surface, Symposium, talented, television, temozolomide, Thalmann, thehe, tissue, TKI, Toronto, Track, transformative, twelfth, tyrosine, unconstitutional, undermining, underpinning, undo, UPenn, upholding, urgently, Vaccinia, vast, viral, vitro, vivo, vulnerable, wall, Wenchao, women, world, WSS, xenograft, XSCID, young, Zaklady, zone

Removed: adequacy, Africa, aggressively, anhydrase, AppTec, assured, Australia, biomedical, BioReliance, biosynthetic, Brazil, buildout, carbonic, Celgene, chart, clearance, CNDO, collectability, committed, Composite, compound, consolidating, construction, contracted, counterpart, CSR, deliverable, Dermasorb, DiaVax, diverse, diversify, employing, Europe, exempt, expanding, expiring, focused, Forman, fulfilling, GNE, graph, HC, Horin, hyposialylation, incorporate, index, India, individualized, insider, IX, Japan, jointly, laser, leukemic, liquidity, ManNAc, marketable, master, measure, migraine, myopathy, nephropathy, NZP, owed, paradigm, persuasive, PK, pledging, poly, polymerase, preservation, Progenitor, programmed, projected, proposal, prospectively, quizartinib, readily, recall, recording, reflecting, reinvestment, relapsing, relationship, remission, rental, rented, retrospectively, satisfying, sensitivity, separability, separable, separately, Serial, shipment, sialic, Simplifying, Singapore, specialty, staffing, Stephen, stimulation, straight, sublease, surrendered, SVP, tolerability, trademark, undergoing, Vidaza, WuXi, yield, Zealand

	·	Aevitas Therapeutics, Inc. (Delaware)
	·	Avenue Therapeutics, Inc. (Delaware)’
	·	Caelum Biosciences, Inc. (Delaware), formerly FBIO Acquisition Corp. II
	·	CB Securities Corporation (Massachusetts)
	·	Cellvation Inc. (Delaware), formerly FBIO Acquisition Corp. I
	·	Checkpoint Therapeutics, Inc. (Delaware)
	·	Cyprium Therapeutics, Inc. (Delaware)
	·	Coronado SO Co. (Delaware)
	·	Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc. (Delaware)
	·	FBIO Acquisition Corp. IV, VI – XIV (Delaware)
	·	GeneXion Oncology, Inc. (Delaware), formerly FBIO Acquisition Corp. III
	·	Helocyte, Inc., formerly DiaVax Biosciences, Inc. (Delaware)
	·	Innmune Limited (United Kingdom)
	·	Journey Medical Corporation (Delaware)
	·	Mustang Bio, Inc. (Delaware)
	·	Tamid Bio, Inc. (Delaware), formerly FBIO Acquisition Corp. V
	·	Fortress Biotech, China, Inc.

Fortress Biotech (FBIO) 10-K2018 FY Annual report

Content analysis